Hailing Guo

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial

Vanita R. Aroda, Julio Rosenstock, Carol Wysham et al. · Diabetes Care · 2016 · 256 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone ( <scp>GetGoal</scp> ‐P)

M. Pinget, Ronald Goldenberg, Elisabeth Niemoeller et al. · Diabetes Obesity and Metabolism · 2013 · 137 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections

Richard M. Bergenstal, Timothy S. Bailey, David Rodbard et al. · Diabetes Care · 2017 · 122 citations

Medicine, Endocrinology, Pharmacotherapy +17

Lixisenatide Therapy in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Antidiabetic Treatment: The GetGoal-O Randomized Trial

Graydon S. Meneilly, Christine Roy-Duval, Hasan Alawi et al. · Diabetes Care · 2017 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +17